Free Trial

Genpact (NYSE:G) Upgraded to "Strong-Buy" at Wall Street Zen

Genpact logo with Business Services background

Wall Street Zen upgraded shares of Genpact (NYSE:G - Free Report) from a buy rating to a strong-buy rating in a research note published on Friday.

A number of other analysts also recently weighed in on the stock. Robert W. Baird decreased their price target on shares of Genpact from $56.00 to $50.00 and set a "neutral" rating for the company in a research report on Thursday, May 8th. TD Cowen upgraded Genpact from a "hold" rating to a "buy" rating and lifted their price target for the stock from $45.00 to $60.00 in a research note on Friday, February 7th. Needham & Company LLC decreased their price target on Genpact from $55.00 to $50.00 and set a "buy" rating for the company in a research note on Thursday, May 8th. Finally, Mizuho lifted their price target on Genpact from $45.00 to $55.00 and gave the stock a "neutral" rating in a research note on Monday, February 10th. Four investment analysts have rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $50.71.

Check Out Our Latest Stock Analysis on Genpact

Genpact Stock Up 0.2%

Shares of Genpact stock traded up $0.07 during trading hours on Friday, hitting $43.20. 2,395,192 shares of the company's stock traded hands, compared to its average volume of 1,381,660. The stock has a 50 day simple moving average of $45.83 and a 200-day simple moving average of $47.22. The company has a quick ratio of 1.85, a current ratio of 2.16 and a debt-to-equity ratio of 0.50. The company has a market cap of $7.55 billion, a PE ratio of 15.21, a PEG ratio of 1.84 and a beta of 0.94. Genpact has a twelve month low of $30.38 and a twelve month high of $56.76.

Genpact (NYSE:G - Get Free Report) last announced its earnings results on Wednesday, May 7th. The business services provider reported $0.84 earnings per share for the quarter, beating the consensus estimate of $0.80 by $0.04. Genpact had a return on equity of 22.50% and a net margin of 10.77%. The company had revenue of $1.21 billion during the quarter, compared to the consensus estimate of $1.21 billion. During the same period last year, the firm earned $0.73 earnings per share. The company's revenue was up 7.4% on a year-over-year basis. Equities research analysts anticipate that Genpact will post 3.21 earnings per share for the current fiscal year.

Genpact Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, June 30th. Shareholders of record on Wednesday, June 18th will be issued a $0.17 dividend. This represents a $0.68 dividend on an annualized basis and a yield of 1.57%. The ex-dividend date is Wednesday, June 18th. Genpact's dividend payout ratio is presently 23.21%.

Insiders Place Their Bets

In other news, CEO Balkrishan Kalra sold 13,600 shares of the business's stock in a transaction that occurred on Thursday, March 13th. The stock was sold at an average price of $48.89, for a total transaction of $664,904.00. Following the completion of the transaction, the chief executive officer now directly owns 310,246 shares in the company, valued at approximately $15,167,926.94. The trade was a 4.20% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Nicholas C. Gangestad acquired 2,000 shares of Genpact stock in a transaction dated Tuesday, May 13th. The shares were acquired at an average price of $43.97 per share, with a total value of $87,940.00. Following the completion of the transaction, the director now owns 2,000 shares of the company's stock, valued at approximately $87,940. This trade represents a ∞ increase in their position. The disclosure for this purchase can be found here. 3.07% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Genpact

Several hedge funds and other institutional investors have recently made changes to their positions in G. Sumitomo Mitsui Trust Group Inc. acquired a new position in shares of Genpact during the first quarter worth approximately $115,807,000. Norges Bank acquired a new stake in Genpact in the fourth quarter worth about $90,516,000. Tandem Investment Advisors Inc. lifted its holdings in Genpact by 390.5% in the fourth quarter. Tandem Investment Advisors Inc. now owns 2,129,915 shares of the business services provider's stock worth $91,480,000 after purchasing an additional 1,695,706 shares during the period. Victory Capital Management Inc. lifted its holdings in Genpact by 18.1% in the fourth quarter. Victory Capital Management Inc. now owns 9,853,437 shares of the business services provider's stock worth $423,205,000 after purchasing an additional 1,511,790 shares during the period. Finally, Lord Abbett & CO. LLC acquired a new stake in Genpact in the fourth quarter worth about $60,110,000. 96.03% of the stock is currently owned by institutional investors and hedge funds.

Genpact Company Profile

(Get Free Report)

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.

Featured Stories

Analyst Recommendations for Genpact (NYSE:G)

Should You Invest $1,000 in Genpact Right Now?

Before you consider Genpact, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.

While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

Goldman Sachs Warns of 20% Market Drop—Are They Right?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines